FEND TB Submission Form
We invite developers of TB diagnostics to submit proposals for the evaluation of early-stage TB diagnostics and novel testing strategies. For any questions, contact us at fendtech@rutgers.edu.
Submission will be accepted from January 31 to April 30, 2026.
Requesting a CDA is optional and will delay the review process.
Please populate the PowerPoint template provided above. You will be prompted to submit the presentation on the final page of the submission form.
If you are unable to access the Google Form, please request a PDF version by emailing fendtech@njms.rutgers.edu.
You will receive a copy of your submission at the email address provided. In the event that your submission is not selected this cycle, you may use the link in that email to edit and resubmit in a future cycle.
FEND-TB Conflict of Interest Disclaimer
The Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND-TB) program, led by Rutgers University in collaboration with multiple global partners, includes investigators who may have research-related relationships with diagnostic manufacturers. These relationships may involve receipt of research support, equipment, reagents, or other resources provided for independent evaluation under appropriate institutional oversight.
All FEND-TB evaluations are conducted according to established scientific and ethical standards, with full adherence to institutional conflict-of-interest policies and procedures. The presence of such relationships does not influence the objectivity, integrity, or independence of the evaluation process.